India sets 2026 health agenda: Drug quality, innovation, TB and obesity take centre stage
The Indian government plans to enhance drug quality and digital health by 2026, with a focus on good manufacturing practices. The pharmaceutical market is expected to expand significantly, but small manufacturers face challenges in compliance and capital investment.
The Indian government plans to enhance drug quality and digital health by 2026, with a focus on good manufacturing practices. The pharmaceutical market is expected to expand significantly, but small manufacturers face challenges in compliance and capital investment.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
